31/08/2026
Hospitals face an ongoing challenge from ESKAPE pathogens: a group of bacteria associated with healthcare-associated infections and known for their ability to develop resistance to antimicrobial treatments.
BioCote® antimicrobial technology has been independently tested by a third-party laboratory against all six ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) using the recognised ISO 22196 test method.
The results showed more than 99% reduction after 24 hours on BioCote® treated surfaces under laboratory test conditions. BioCote® helps provide an added layer of product protection between routine cleaning cycles; it does not replace established cleaning, hygiene or infection-prevention measures.
See more: https://eu1.hubs.ly/H0xWMR70